<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The aberrant methylation of CpG islands in the promoter is associated with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In our previous study, the promoter of alcohol dehydrogenase, iron containing, 1 (ADHFE1) was most highly methylated in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> compared to <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal mucosa </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we examined the expression and function of the ADHFE1 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We examined the promoter methylation and <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of ADHFE1 with <z:chebi fb="0" ids="50131">5-aza-2'-deoxycytidine</z:chebi> (5-Aza-2-dC) in 12 CRC cell lines, 124 paired <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa, and 59 advanced <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>To confirm methylation of ADHFE1, we performed <z:chebi fb="0" ids="17137">bisulfite</z:chebi> genomic sequencing in 3 CRC cell lines, 6 paired <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa </plain></SENT>
<SENT sid="5" pm="."><plain>ADHFE1 protein expression was studied using western blot and immunohistochemistry, respectively in the 36 and 243 paired <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> tissue </plain></SENT>
<SENT sid="6" pm="."><plain>We transfected the DLD-1 with pcDNA3.1 vector containing ADHFE1 and examined the expression of differentiation marker, such as ALP, CEA and Cdx2 </plain></SENT>
<SENT sid="7" pm="."><plain>We examined the ADHFE1 expression at distinct developmental stages in mouse embryos </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: The ADHFE1 promoter was hypermethylated in <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines, 81.8% in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>, and 84.7% in advanced <z:mpath ids='MPATH_270'>adenomas</z:mpath>, with reciprocal change by 5-Aza-2-dC </plain></SENT>
<SENT sid="9" pm="."><plain>The expression of ADHFE1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> was down-regulated in <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines and 96.3% in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues </plain></SENT>
<SENT sid="10" pm="."><plain>The expression of ADHFE1 protein was down-regulated in 91.7% of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues </plain></SENT>
<SENT sid="11" pm="."><plain>In the immunohistochemistry, <z:mpath ids='MPATH_458'>normal</z:mpath> epithelial cells at the crypt top showed very strong ADHFE1 expression, whereas they were much weaker at the crypt base </plain></SENT>
<SENT sid="12" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, the good differentiation was significantly associated with high ADHFE1 expression </plain></SENT>
<SENT sid="13" pm="."><plain>The activity of differentiation marker, such as ALP and CEA, was higher in pcDNA3.1-ADHFE1 transfected <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells with consistent correlation with ADHFE1 protein than control </plain></SENT>
<SENT sid="14" pm="."><plain>In mouse embryos, ADHFE1 in the large intestine was the first detected at E15.5 </plain></SENT>
<SENT sid="15" pm="."><plain>At E18.5, ADHFE1 was predominantly expressed in the top of the mature crypt epithelium </plain></SENT>
<SENT sid="16" pm="."><plain>CONCLUSIONS: It showed that the hypermethylation of ADHFE1 promoter in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> is concordance with down-regulation of ADHFE1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> and ADHFE1 protein </plain></SENT>
<SENT sid="17" pm="."><plain>ADHFE1 has an important role of differentiation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, as well as <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal mucosa and embryonic developmental processes </plain></SENT>
</text></document>